Welcome to our dedicated page for AIRGAIN SEC filings (Ticker: AIRG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AIRGAIN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AIRGAIN's regulatory disclosures and financial reporting.
Airgain, Inc. director James K. Sims received new equity awards. On February 2, 2026, he was granted 10,885 restricted stock units with a grant price of $0. All of these RSUs vest on February 2, 2027, if he continues serving the company through that date.
He also received a stock option for 18,991 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. After these awards, he directly holds 433,223 shares of common stock, which includes RSUs, and 18,991 stock options.
Airgain, Inc. director Thomas A. Munro received new equity awards in the form of restricted stock units and stock options. On February 2, 2026, he was granted 7,257 shares of common stock as RSUs at a price of $0, bringing his directly held and RSU-included common stock holdings to 84,171 shares. He was also granted a stock option covering 12,660 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036, contingent on continued service.
Airgain, Inc. director Joan H. Gillman received new equity awards as part of her compensation. On February 2, 2026, she was granted 7,257 shares of common stock in the form of restricted stock units at no cost, which all vest on February 2, 2027 if she continues serving the company.
She also received a stock option covering 12,660 shares of common stock with an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. After these grants, she beneficially owns 43,991 shares of Airgain common stock, including RSUs, held directly.
Airgain, Inc. director T J Chung received new equity awards in the form of restricted stock units and stock options. On February 2, 2026, Chung was granted 7,257 RSUs at a price of $0, which fully vest on February 2, 2027, if service continues. On the same date, Chung received a stock option for 12,660 shares at an exercise price of $4.27 per share, vesting 100% on February 2, 2027 and expiring on February 1, 2036. Following these grants, Chung directly beneficially owned 51,015 shares of common stock, including RSUs, and 12,660 stock options.
Airgain, Inc. director Kiva A. Allgood reported new equity awards consisting of restricted stock units and stock options. On February 2, 2026, Allgood received 7,257 restricted stock units, each representing one share of common stock, at a grant price of $0, all vesting on February 2, 2027, subject to continued service.
On the same date, Allgood was also granted a stock option covering 12,660 shares of common stock at an exercise price of $4.27 per share. The option vests in full on February 2, 2027, contingent on continued service, and will be exercisable through February 1, 2036. Following these grants, Allgood directly beneficially owned 36,849 shares of common stock, including RSUs.
Airgain, Inc. President and CEO Jacob Suen, who is also a director, reported an automatic sale of common stock linked to equity compensation. On January 20, 2026, he sold 15,993 shares of Airgain common stock at a weighted average price of $3.996 per share, with individual trade prices ranging from $3.9838 to $3.9966. The filing states that these shares were sold solely to cover tax withholding obligations arising from the vesting and settlement of restricted stock units through a pre-arranged "sell-to-cover" instruction.
The transaction is described as non-discretionary, executed under an instruction letter intended to meet the affirmative defense conditions of Rule 10b5-1. Following this sale, Suen beneficially owned 293,635 shares of Airgain common stock, a figure that includes restricted stock units.
Airgain, Inc. Chief Technology Officer Sadri Ali reported an automatic sale of 4,733 shares of common stock on January 20, 2026 to cover tax withholding obligations. The shares were sold through a "sell-to-cover" transaction tied to the vesting and settlement of restricted stock units, described as a non-discretionary arrangement under an instruction letter intended to satisfy Rule 10b5-1 affirmative defense conditions.
The sale had a weighted average price of $3.9963 per share, with individual trades executed between $3.9900 and $3.9966. Following this tax-related sale, Ali beneficially owned 127,030 shares of Airgain common stock, which includes RSUs.
Airgain, Inc. Chief Financial Officer Michael Elbaz reported an automatic sale of company stock tied to equity compensation. On January 20, 2026, he sold 4,587 shares of Airgain common stock at a weighted average price of $3.9961 per share. The filing explains that the sale was a "sell-to-cover" transaction to pay tax withholding obligations arising from the vesting and settlement of Restricted Stock Units, and is not a discretionary trade. Following this transaction, Elbaz beneficially owned 133,106 shares of Airgain common stock, including RSUs. The instruction for these automatic sales is intended to satisfy the affirmative defense conditions of Rule 10b5-1.
Airgain, Inc. insider filing: The company’s President and CEO, who is also a director, reported the sale of 2,070 shares of Airgain common stock on 11/24/2025. The shares were sold at a weighted average price of $3.9895 per share, in multiple trades within a price range of $3.9818 to $4.1129.
The filing explains that this was a “sell to cover” transaction, where shares were automatically sold to cover tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs). It states that the transaction was not a discretionary trade by the executive and was carried out under an instruction letter intended to satisfy the affirmative defense conditions of Rule 10b5-1.
After this transaction, the reporting person beneficially owns 309,628 shares of Airgain common stock, which includes RSUs.
Airgain, Inc. Chief Technology Officer reports small share sale to cover taxes. A company officer filed a Form 4 showing the sale of 976 shares of Airgain common stock on 11/24/2025 at a weighted average price of $3.9894 per share. After this transaction, the officer beneficially owns 131,763 shares, which include Restricted Stock Units (RSUs).
The filing explains that the sale was made solely to cover tax withholding obligations arising from the vesting and settlement of RSUs and is described as a non-discretionary “sell-to-cover” transaction. The officer has an instruction letter in place so these tax-related sales are executed automatically under a plan intended to meet the affirmative defense conditions of Rule 10b5-1.